Condition
Myelodysplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Myelodysplasia clinical trials that are recruiting, at sites in 2 countries (most in United States (4), France (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Myelodysplasia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Low-dose post-transplant cyclophosphamide plus tacrolimus and ruxolitinib to prevent GVHD after myeloablative peripheral blood stem cell transplant | Phase 2 | Birmingham, Alabama and 2 other locations | Recruiting | Nov 25, 2025 |
| Targeted T-Cell and B-Cell Depletion for Hematologic Malignancies | — | Milwaukee, Wisconsin | Recruiting | Apr 3, 2023 |
| T cell receptor depletion for blood cancer treatment | Phase 2 | Minneapolis, Minnesota | Recruiting | Feb 21, 2023 |
| Evaluating anti-platelet antibodies in diagnosing autoimmune thrombocytopenia | — | Pessac | Recruiting | Mar 16, 2021 |
| Hematopoietic stem cell transplant for blood cancers | Phase 2 | Minneapolis, Minnesota | Recruiting | Oct 19, 2017 |
All recruiting trials (5)
-
Low-dose post-transplant cyclophosphamide plus tacrolimus and ruxolitinib to prevent GVHD after myeloablative peripheral blood stem cell transplant
This test sees if adding low-dose post-transplant cyclophosphamide with tacrolimus and ruxolitinib can reduce severe acute graft-versus-host disease in adults receiving myeloablative peripheral blood stem cell transplants for leukemia or myelodysplasia.
-
Targeted T-Cell and B-Cell Depletion for Hematologic Malignancies
This study is testing a new way to prepare patients with blood cancers for stem cell transplants by removing certain immune cells to see if it helps them recover better and stay healthy longer.
-
T cell receptor depletion for blood cancer treatment
This study is testing a new way to treat blood cancers by using a special treatment before a stem cell transplant to see if it helps both kids and adults do better after the procedure.
-
Evaluating anti-platelet antibodies in diagnosing autoimmune thrombocytopenia
This study is testing if checking for specific antibodies in the blood can help doctors diagnose immune thrombocytopenia in adults with low platelet counts.
-
Hematopoietic stem cell transplant for blood cancers
This study is testing two different ways of doing stem cell transplants for people with blood cancers to see which method works better and is safer.
Related topics
Quick answers
How many Myelodysplasia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.